The Role of Protease Inhibitor Therapy in Children with HIV Infection

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.4, Iss.9, 2002-01, pp. : 581-607

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dual protease inhibitor therapy in the management of the HIV-1

By Yu K. Daar E.S.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 7, 2000-12 ,pp. : 1331-1342

Informa Healthcare

Access to resources Recommend Favorite

Metabolic Complications Associated with HIV Protease Inhibitor Therapy

By Nolan D.

Drugs, Vol. 63, Iss. 23, 2003-01 ,pp. : 2555-2574

Adis International

Access to resources Recommend Favorite

Nevirapine-based HAART is more effective than protease inhibitor (PI)-based HAART in antiretroviral therapy-naive pregnant women with HIV infection

Inpharma, Vol. 1, Iss. 1590, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Emtricitabine/Tenofovir Disoproxil Fumarate: In Combination with a Protease Inhibitor in HIV-1 Infection

By Perry Caroline M.

Drugs, Vol. 69, Iss. 7, 2009-05 ,pp. : 843-857

Adis International

Access to resources Recommend Favorite

Tipranavir: a novel non-peptidic protease inhibitor for the treatment of HIV infection

By Mehandru Saurabh Markowitz Martin

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1821-1828

Informa Healthcare

Access to resources Recommend Favorite